This review synthesizes current evidence on the interplay between the aryl hydrocarbon receptor (AhR), G protein-coupled receptor 35 (GPR35), cytochrome P450 enzymes, and dietary ligands in the context of inflammatory bowel disease (IBD) and colorectal cancer (CRC). This evidence concerns the gene AHR and colorectal cancer.